William Pickering
Stock Analyst at Bernstein
(1.31)
# 3,228
Out of 5,128 analysts
31
Total ratings
50%
Success rate
-6.07%
Average return
Main Sectors:
Top Industries:
Stocks Rated by William Pickering
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BBIO BridgeBio Pharma | Initiates: Outperform | $94 | $74.27 | +26.57% | 1 | Dec 11, 2025 | |
| BHVN Biohaven | Downgrades: Market Perform | $34 → $9 | $11.74 | -23.34% | 3 | Nov 6, 2025 | |
| BIIB Biogen | Maintains: Market Perform | $155 → $157 | $186.91 | -16.00% | 1 | Nov 3, 2025 | |
| BMRN BioMarin Pharmaceutical | Maintains: Outperform | $95 → $88 | $61.31 | +43.53% | 5 | Nov 3, 2025 | |
| NTLA Intellia Therapeutics | Downgrades: Market Perform | $14 → $15 | $10.13 | +43.14% | 2 | Oct 28, 2025 | |
| RNA Avidity Biosciences | Downgrades: Market Perform | $52 → $72 | $72.37 | -0.51% | 1 | Oct 27, 2025 | |
| REGN Regeneron Pharmaceuticals | Maintains: Outperform | $753 → $781 | $812.27 | -3.85% | 3 | Aug 27, 2025 | |
| SRPT Sarepta Therapeutics | Initiates: Market Perform | $13 | $23.46 | -44.59% | 1 | Jul 29, 2025 | |
| ALNY Alnylam Pharmaceuticals | Maintains: Outperform | $314 → $310 | $422.50 | -26.63% | 2 | Jan 7, 2025 | |
| ARWR Arrowhead Pharmaceuticals | Maintains: Market Perform | $27 → $24 | $65.69 | -63.46% | 2 | Nov 29, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Market Perform | n/a | $83.17 | - | 2 | Jun 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $484.15 | - | 5 | Feb 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Market Perform | $37 | $28.93 | +27.89% | 1 | Mar 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Market Perform | $6 | $1.49 | +302.68% | 1 | Mar 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Market Perform | $44 | $57.99 | -24.12% | 1 | Mar 21, 2023 |
BridgeBio Pharma
Dec 11, 2025
Initiates: Outperform
Price Target: $94
Current: $74.27
Upside: +26.57%
Biohaven
Nov 6, 2025
Downgrades: Market Perform
Price Target: $34 → $9
Current: $11.74
Upside: -23.34%
Biogen
Nov 3, 2025
Maintains: Market Perform
Price Target: $155 → $157
Current: $186.91
Upside: -16.00%
BioMarin Pharmaceutical
Nov 3, 2025
Maintains: Outperform
Price Target: $95 → $88
Current: $61.31
Upside: +43.53%
Intellia Therapeutics
Oct 28, 2025
Downgrades: Market Perform
Price Target: $14 → $15
Current: $10.13
Upside: +43.14%
Avidity Biosciences
Oct 27, 2025
Downgrades: Market Perform
Price Target: $52 → $72
Current: $72.37
Upside: -0.51%
Regeneron Pharmaceuticals
Aug 27, 2025
Maintains: Outperform
Price Target: $753 → $781
Current: $812.27
Upside: -3.85%
Sarepta Therapeutics
Jul 29, 2025
Initiates: Market Perform
Price Target: $13
Current: $23.46
Upside: -44.59%
Alnylam Pharmaceuticals
Jan 7, 2025
Maintains: Outperform
Price Target: $314 → $310
Current: $422.50
Upside: -26.63%
Arrowhead Pharmaceuticals
Nov 29, 2024
Maintains: Market Perform
Price Target: $27 → $24
Current: $65.69
Upside: -63.46%
Jun 14, 2024
Upgrades: Market Perform
Price Target: n/a
Current: $83.17
Upside: -
Feb 2, 2024
Downgrades: Market Perform
Price Target: n/a
Current: $484.15
Upside: -
Mar 21, 2023
Initiates: Market Perform
Price Target: $37
Current: $28.93
Upside: +27.89%
Mar 21, 2023
Initiates: Market Perform
Price Target: $6
Current: $1.49
Upside: +302.68%
Mar 21, 2023
Initiates: Market Perform
Price Target: $44
Current: $57.99
Upside: -24.12%